Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
Timothy Kottke(Mayo Clinic in Arizona), Richard G. Vile(Mayo Clinic), John Chester(Velindre Cancer Centre), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Jill Thompson(Mayo Clinic), Glen N. Barber(Immunité et Cancer), Alan Melcher(University College Hospital), Candice Willmon(Mayo Clinic), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Phonphimon Wongthida(Mayo Clinic), Feorillo Galivo(Oregon Health & Science University), Karen M. Kaluza(Mayo Clinic), José S. Pulido(Wills Eye Hospital), Peter J. Selby(Centre for Addiction and Mental Health), Rosa María Díaz(Mayo Clinic)
Cited by 47
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k